AT WHAT AGE CAN YOU
START PUBERTY BLOCKERS?
There is no single age at which a young person can start puberty blockers. Medical guidelines tie the timing to a stage of puberty rather than a birthday: the medication is considered only after puberty has actually begun, at what clinicians call Tanner stage 2. Because puberty starts at different ages for different children, that can correspond to a range of ages, often somewhere from about 7 to 13, but the trigger is the pubertal stage, not the number. And reaching that stage is not enough on its own: starting also requires assessment by a specialist team, informed agreement from the young person, and, for minors, parental consent.
This distinction, stage rather than age, is the key to answering the question accurately. This page explains what the guidelines actually say, what Tanner stage 2 means and roughly when it happens, what else has to be in place before starting, and how the timing of later steps differs. Throughout, "puberty-pausing medication" refers to the same thing as "puberty blockers"; the terms are interchangeable, and this page uses the plain-language one after the first mention.
CONTENT NOTE
If your teen is in crisis or thinking about suicide, help is available right now. Call or text 988 (the 988 Suicide & Crisis Lifeline). For more, see our where to get help page.
-
It's a stage, not an age. Guidelines tie the start of puberty-pausing medication to Tanner stage 2, which is the first physical signs of puberty, not to a fixed birthday.
-
Not before puberty. Before puberty begins, no medical treatment is used at all. Support is social and psychological only.
-
The stage varies by child. Tanner stage 2 typically arrives around ages 7 to 13, with wide
individual variation.
-
Stage alone isn't enough. Starting also requires specialist assessment, the young person's informed agreement, and, for minors, parental consent.
-
Hormones come later. Gender-affirming hormones are a separate, later step, generally for older adolescents, not the same decision as pausing puberty.
KEY TAKEAWAYS
WHY THE ANSWER IS A STAGE
Guidelines set the timing by pubertal development because the medication's purpose is to pause changes that have just begun, which is only relevant once puberty starts. The Endocrine Society's dosing standards state that pubertal suppression with GnRH agonists can start at the earliest stages of puberty, Tanner stage 2. The Endocrine Society advises beginning only after a young person first shows physical changes of puberty (Tanner stages G2/B2). Starting earlier would serve no purpose, because there is nothing yet to pause; starting well after puberty has advanced means some changes have already occurred.
Because children enter puberty at different ages, that same stage lands at different ages for different young people, which is exactly why a fixed age doesn't capture it.
WHAT TANNER STAGE 2 IS, AND WHEN IT HAPPENS
Tanner stage 2 is the earliest visible sign of puberty, and it typically appears somewhere in a range of ages, not at one set point. It marks the first physical changes: the breast-bud stage in those assigned female, and an increase in testicular volume in those assigned male. According to a 2024 review in Frontiers in Endocrinology, these first changes typically occur across the following age ranges.
As Mayo Clinic notes, puberty generally begins around age 10 or 11 but may start earlier or later, and the medication's effect depends on when it is begun. Clinicians confirm the stage through examination, sometimes supported by blood tests, rather than going by a child's age alone.
Source: Frontiers in Endocrinology (2024). These are typical ranges. Individual timing varies, and clinicians assess the stage directly rather than relying on age.
WHAT ELSE HAS TO BE IN PLACE BEFORE STARTING
Reaching Tanner stage 2 makes a young person potentially eligible, but several other conditions must be met first. Puberty-pausing medication is not started on the basis of age or stage alone. Per the Endocrine Society guideline, starting generally requires that:
-
a young person meets the diagnostic criteria, and a specialist team has assessed them, often across several visits;
-
the young person understands the treatment and gives informed agreement (assent);
-
for minors, a parent or guardian provides consent. In nearly all cases, the medication cannot be started without it;
-
a mental health provider is involved in the assessment.
In other words, the stage of puberty opens the door, and the assessment and consent process determines whether and when to walk through it. For what that evaluation looks like, see our page on questions to ask a gender clinic, and for how the medication itself works, see our page on what puberty-pausing medication is.
WHAT ABOUT STARTING HORMONES?
Gender-affirming hormones are a separate, later decision, not the same as pausing puberty. The Endocrine Society guideline describes hormones being added only after a multidisciplinary team confirms that gender dysphoria has persisted and that the young person has the capacity to give informed consent, a capacity it notes most adolescents reach by about age 16. So while puberty-pausing medication can begin in early puberty, hormones typically come in later adolescence. For the fuller sequence, see how gender-affirming care works.
ONE IMPORTANT CAVEAT:
ELIGIBILITY IS NOT THE SAME AS AVAILABILITY
What the medical guidelines allow and what is legally available where a family lives are now two different questions in the United States. The clinical timing described on this page reflects medical guidelines. Separately, many US states have passed laws restricting or banning this care for minors, and that legal landscape is changing. So the medical answer ("when puberty begins, with assessment and consent") may differ from what is actually accessible in a given state at a given time. Because this shifts frequently, check the current situation for your state; our coverage of laws and access tracks it, and this page reflects the medical guidance as of 2026.